SLG
LLY icon

Stanley-Laman Group’s Eli Lilly LLY Stock Holding History

Stanley-Laman Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.24M Buy
6,787
+322
+5% +$326K 0.77% 31
2025
Q4 		$6.95M Buy
6,465
+2,665
+70% +$2.55M 0.88% 24
2025
Q3 		$2.9M Sell
3,800
-169
-4% -$126K 0.41% 93
2025
Q2 		$3.09M Sell
3,969
-1,493
-27% -$1.16M 0.46% 99
2025
Q1 		$4.51M Buy
5,462
+185
+4% +$154K 0.69% 48
2024
Q4 		$4.07M Sell
5,277
-3
-0.1% -$2.48K 0.57% 71
2024
Q3 		$4.68M Sell
5,280
-103
-2% -$92.6K 0.66% 51
2024
Q2 		$4.87M Sell
5,383
-4,438
-45% -$3.55M 0.7% 42
2024
Q1 		$7.64M Sell
9,821
-2,073
-17% -$1.48M 1.07% 15
2023
Q4 		$6.93M Sell
11,894
-1,558
-12% -$909K 1.06% 26
2023
Q3 		$7.23M Sell
13,452
-597
-4% -$308K 1.23% 13
2023
Q2 		$6.59M Sell
14,049
-1,678
-11% -$704K 1.09% 20
2023
Q1 		$5.4M Sell
15,727
-122
-0.8% -$41.1K 0.96% 23
2022
Q4 		$5.8M Sell
15,849
-662
-4% -$235K 1.1% 15
2022
Q3 		$5.34M Sell
16,511
-802
-5% -$254K 1.01% 22
2022
Q2 		$5.61M Sell
17,313
-1,689
-9% -$507K 1% 21
2022
Q1 		$5.44M Buy
19,002
+2,350
+14% +$605K 0.75% 31
2021
Q4 		$4.6M Buy
16,652
+1,422
+9% +$360K 0.54% 48
2021
Q3 		$3.52M Buy
15,230
+1,261
+9% +$311K 0.46% 49
2021
Q2 		$3.21M Buy
13,969
+1,304
+10% +$262K 0.46% 49
2021
Q1 		$2.37M Buy
12,665
+754
+6% +$147K 0.39% 62
2020
Q4 		$2.01M Sell
11,911
-617
-5% -$92.1K 0.36% 70
2020
Q3 		$1.85M Buy
+12,528
New +$1.94M 0.41% 64
2020
Q2 		– Sell
-2,002
Closed -$278K – 248
2020
Q1 		$278K Buy
+2,002
New +$275K 0.08% 206
2014
Q1 		– Sell
-29,601
Closed -$1.51M – 329
2013
Q4 		$1.51M Buy
+29,601
New +$1.48M 0.33% 96

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stanley-Laman Group's LLY Position: Q1 2026 in Review

Stanley-Laman Group increased its Eli Lilly (LLY) stake by 5% in Q1 2026, buying an estimated $326K and bringing the position to 6,787 shares worth $6.24M. The position accounts for 0.77% of the portfolio, ranked #31.

Stanley-Laman Group first reported a position in LLY in Q4 2013 and has held it in 25 quarters since. The position peaked at $7.64M in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Stanley-Laman Group held 6,787 shares of Eli Lilly worth $6.24M as of Q1 2026.
  • Stanley-Laman Group bought 322 Eli Lilly shares in Q1 2026, an estimated $326K.
  • Eli Lilly made up 0.77% of Stanley-Laman Group's portfolio in Q1 2026, its #31 holding.
  • Stanley-Laman Group first reported a position in Eli Lilly in Q4 2013 and has held it in 25 quarters since.
  • Stanley-Laman Group's Eli Lilly position peaked at $7.64M in Q1 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stanley-Laman Group's 13F filing for Q1 2026, filed 16 Apr 2026.